HALMED Confirms News That EMA Starts Review of Sputnik V

HALMED recalls that Sputnik V jab was developed by the Russian Gamaleya Research Institute of Epidemiology and Microbiology.

The European Medicines Agency (EMA) said in a statement on Thursday that the rolling review is based on results from laboratory studies and clinical studies in adults.

The Russian vaccine has been deployed in 40 countries worldwide, including European nations Serbia, Montenegro, Moldova, and Hungary. Slovakia received its first shipment of 200,000 doses over the weekend, the Euronews said on its website.

The EMA has so far approved three vaccines for use across the bloc. These were developed by Pfizer/BioNTech, AstraZeneca/Oxford University, and Moderna. It is currently evaluating the jab by Johnson & Johnson and is expected to give its approval in mid-March.

On Wednesday, Croatian Health Minister Vili Beroš said he had held talks with a Russian delegation on Tuesday on Sputnik V vaccines.

He said that during the meeting he had called for expediting the delivery of documentation on the Russian COVID-19 vaccine so that Croatia’s HALMED regulator could evaluate the vaccine’s safety and efficiency.

 

Subscribe to our newsletter

the fields marked with * are required

Email: *
First name:
Last name:
Gender:	Male Female
Country:
Birthday:	[DD] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 [MM] 1 2 3 4 5 6 7 8 9 10 11 12 [YYYY] 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Please don't insert text in the box below!